|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Amazon Biotech Inc., of New York, signed an interim letter of agreement with the Immunology Clinic of New York to conduct a Phase I/II, randomized, double-blind, placebo-controlled study to test the safety and efficacy of its botanical drug product, AMZ0026, in pre-symptomatic HIV-positive patients undergoing no other anti-retroviral therapies. The company is negotiating with other investigative sites, including hospital clinics, to participate in the study.
o Biovest International Inc., of Worcester, Mass., received approval from the Russian Ministry of Health and Social Development to recruit patients for its ongoing Phase III trial of BiovaxID in indolent ...